Daunorubicin

Beijing Global Biologicals Co., Ltd is a manufacturer, trading company and service provider positioning itself as a market-oriented, biotechnology-driven 'BioHub' spanning alkaloids, hormones, enzymes, vitamins, prostaglandins, antibiotics (including tetracyclines, penicillin and cephalosporins), cytokines, peptides, phospholipids and chiral intermediates. Started up by Dr. FuJu Wang in 2012, the company built production factories in Heze (2014) and Jining (2016), was recognized as a National Hi-Tech Enterprise in 2018, and became a 'Little Giant' enterprise near the STAR Market board in 2022. Its BioLab-to-BioFab model takes projects from discovery through active ingredients and finished dosage forms, drawing on a team of scientists, technicians and engineers with experience across more than 100 projects and a substantial portfolio of patents and technical know-how in strains, enzymes and fermentation technologies. The company offers CRO services alongside outsourcing, custom synthesis and consultation, selling worldwide across North and South America, Western and Eastern Europe, Australasia, the Middle East, Africa and Asia.